• Sector: Healthcare
  • Geography: Americas
  • Stage: Late
  • Investment Year: 1997
  • Exit Year: 2003
  • Website Link

Coventry Health Care, Inc.

In 1997, Warburg Pincus invested in Coventry Health Care (Coventry), an operator of health maintenance organizations (HMOs) and other health plans. Warburg Pincus identified Coventry as a market leading brand in an attractive market with numerous opportunities to grow revenue and improve its financial position. After acquiring Coventry, the Warburg Pincus team worked with the company to pursue strategic top and bottom line growth initiatives. With Warburg Pincus’ support, the company hired a new CEO who had a long and successful history as a senior executive in the managed care industry. Warburg Pincus worked with Coventry to increase organic membership growth and improve its pricing strategy, while also supporting the company’s very active acquisition strategy. With assistance from Warburg Pincus, Coventry completed 15 acquisitions, which added 1.6 million members over six years. Warburg Pincus exited Coventry in 2003.

Website Case Studies Disclaimer

The investments described in the case studies are provided for illustrative purposes only and are not, and do not purport to be, representative of all investments, or all types of investments, previously made by Warburg Pincus, or indicative of the performance of all prior Warburg Pincus investments. The case studies have been selected on the basis of objective criteria that Warburg Pincus believes are representative of the firm’s experience partnering with portfolio company management teams, and of the sectors, stages, strategies and/or geographies in which the firm invests. The information provided in the case studies are not necessarily an indication of future results, and may not be relied up for any purpose. Warburg Pincus’ current or future portfolio companies may differ materially in size, type, performance and other characteristics from the investments presented in the case studies. Further, references in this case study should not be construed as a recommendation or offer to buy or sell any particular security or to make any particular investment.